Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Symbicort
Pharma
AstraZeneca caps out-of-pocket inhaler costs at $35 in the US
At a critical moment for the U.S. inhaler market, AstraZeneca is following its peer Boehringer Ingelheim and taking a step to boost patient access.
Fraiser Kansteiner
Mar 18, 2024 11:02am
AstraZeneca hit by 6 Symbicort marketing rule breaches
Sep 29, 2023 9:20am
AstraZeneca hit by marketing breaches for respiratory meds
Mar 20, 2023 9:25am
The top 10 drug patent expirations of 2023
Mar 13, 2023 3:00am
AZ's first-in-class rescue inhaler Airsupra wins FDA nod
Jan 11, 2023 9:30am
With court win, AZ gets 6 more months protection for Symbicort
Dec 16, 2022 10:02am